These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2312156)

  • 1. IL-2-like activity in lymph fluid following in vivo antigen challenge.
    Bujdoso R; Young P; Hopkins J; McConnell I
    Immunology; 1990 Jan; 69(1):45-51. PubMed ID: 2312156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-random migration of CD4 and CD8 T cells: changes in the CD4: CD8 ratio and interleukin 2 responsiveness of efferent lymph cells following in vivo antigen challenge.
    Bujdoso R; Young P; Hopkins J; Allen D; McConnell I
    Eur J Immunol; 1989 Oct; 19(10):1779-84. PubMed ID: 2511027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological and biochemical characterization of bovine interleukin 2. Studies with cloned bovine T cells.
    Brown WC; Grab DJ
    J Immunol; 1985 Nov; 135(5):3184-90. PubMed ID: 3930599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of adjuvants and prior immunization on the rate and mode of uptake of antigen into afferent popliteal lymph from sheep.
    Beh KJ; Lascelles AK
    Immunology; 1985 Mar; 54(3):487-95. PubMed ID: 3972437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concanavalin A-induced human lymphocyte mitogenic factor: activity distinct from interleukin 1 and 2.
    Duncan MR; George FW; Hadden JW
    J Immunol; 1982 Jul; 129(1):56-62. PubMed ID: 6806367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of lymphoblasts appearing in efferent lymph in response to immunization with vaccinia virus.
    Issekutz TB
    Immunology; 1985 Sep; 56(1):23-31. PubMed ID: 3876275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular requirements for the activation and proliferation of ruminant gammadelta T cells.
    Hanrahan CF; Kimpton WG; Howard CJ; Parsons KR; Brandon MR; Andrews AE; Nash AD
    J Immunol; 1997 Nov; 159(9):4287-94. PubMed ID: 9379024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of lymphokines mediating B cell growth and differentiation from monoclonal anti-CD3 antibody-stimulated T cells.
    Sherris D; Stohl W; Mayer L
    J Immunol; 1989 Apr; 142(7):2343-51. PubMed ID: 2538506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigen-reactive cloned helper T cells. II. Exposure of murine cloned helper T cells to IL 2-containing supernatant induces unresponsiveness to antigenic restimulation and inhibits lymphokine production after antigenic stimulation.
    Wilde DB; Prystowsky MB; Ely JM; Vogel SN; Dialynas DP; Fitch FW
    J Immunol; 1984 Aug; 133(2):636-41. PubMed ID: 6234354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetics of cytotoxic lymphocytes in efferent lymph from single lymph nodes following immunization with vaccinia virus.
    Issekutz TB
    Clin Exp Immunol; 1984 Jun; 56(3):515-23. PubMed ID: 6204794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification of antigen-dependent macrophage migration inhibition factor (MIF) from lymph draining a tuberculin reaction.
    Scott DM; McConnell I; Agomo P; Lachmann PJ
    Immunology; 1978 Apr; 34(4):591-604. PubMed ID: 363599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A mitogenic factor, released by stimulated human mononuclear cells and distinct from interleukin 2 (IL 2), B cell growth factor (BCGF), and interleukin 1 (IL 1).
    Kasakura S; Taguchi M; Watanabe Y; Okubo T; Murachi T; Uchino H; Hanaoka M
    J Immunol; 1984 Dec; 133(6):3084-90. PubMed ID: 6238094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-vivo impaired T helper 1 cell development in submandibular lymph nodes due to IL-12 deficiency following antigen injection into the anterior chamber of the eye.
    Perez VL; Biuckians AJ; Streilein JW
    Ocul Immunol Inflamm; 2000 Mar; 8(1):9-24. PubMed ID: 10806431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissociation in the production of B cell-stimulating factors (BCGF and BCDF) and interleukin 2 by T cells from a common variable immunodeficient patient.
    Saiki O; Shimizu M; Saeki Y; Kishimoto S; Kishimoto T
    J Immunol; 1984 Oct; 133(4):1920-4. PubMed ID: 6088629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bovine interleukin 2: biochemical and biological characterization.
    Arunachalam B; Subba Rao MV; Ram GC
    Vet Immunol Immunopathol; 1989 Dec; 23(3-4):377-83. PubMed ID: 2629200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a novel murine T cell-activating factor.
    Garman RD; Raulet DH
    J Immunol; 1987 Feb; 138(4):1121-9. PubMed ID: 3543122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The production of plasminogen activator by afferent but not efferent lymph cells emigrating from chronic granulomatous lesions in sheep.
    Wasi S; Vadas P; Chin GW; Movat HZ; Hay JB
    J Immunol; 1982 Mar; 128(3):1076-82. PubMed ID: 7199065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigen-induced non-specific suppressor factor in sheep efferent lymph is prostaglandin E2.
    Hopkins J; McConnell I; Raniwalla J
    Immunology; 1981 May; 43(1):205-12. PubMed ID: 7251050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization and partial purification of a specific interleukin 2 inhibitor.
    Honda M; Chan C; Shevach EM
    J Immunol; 1985 Sep; 135(3):1834-9. PubMed ID: 3926886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three functionally distinct helper T-cell clones: the roles for antigen non-specific helper factors in B-cell activation through two different pathways.
    Sano Y; Harada N; Takatsu K
    Immunology; 1985 Dec; 56(4):585-96. PubMed ID: 2934318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.